Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2002 Feb;56(Suppl 1):i30–i36. doi: 10.1136/jech.56.suppl_1.i30

Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?

K Moons, M Bots, J Salonen, P Elwood, d Freire, Y Nikitin, J Sivenius, D Inzitari, V Benetou, J Tuomilehto, P Koudstaal, D Grobbee
PMCID: PMC1765507  PMID: 11815642

Abstract

Background: To decide whether a person with certain characteristics should be given any kind of intervention to prevent a cardiovascular event, it would be helpful to classify subjects in low, medium and high risk categories. The study evaluated which well known cerebrovascular and cardiovascular correlates, in particular fibrinogen level and ECG characteristics, are able to predict the occurrence of stroke in men of the general population using data from three European cohorts participating in EUROSTROKE.

Methods: EUROSTROKE is a collaborative project among ongoing European population based cohort studies and designed as a prospective nested case-control study. For each stroke case two controls were sampled. Strokes were classified according to MONICA criteria or reviewed by a panel of four neurologists. Complete data were available of 698 men (219 stroke events) from cohorts in Cardiff (84 cases/200 controls), Kuopio (74/148) and Rotterdam (61/131). Multivariable logistic regression modeling was used to evaluate which information from history, physical examination (for example, blood pressure), blood lipids, and fibrinogen and ECG measurements independently contributed to the prediction of stroke. The area under receiver operating characteristic curve (ROC area) was used to estimate the predictive ability of models.

Results: Independent predictors from medical history and physical examination were age, stroke history, medically treated hypertension, smoking, diabetes mellitus and diastolic blood pressure. The ROC area of this model was 0.69. After validating and transforming this model to an easy applicable rule, 40% of all future stroke cases could be predicted. Adding pulse rate, body mass index, blood lipids, fibrinogen level and ECG parameters did not improve the classification of subjects in low, medium and high risk. Results were similar when fibrinogen was dichotomised at the upper tertile or quintile.

Conclusion: In the general male population the future occurrence of stroke may be predicted using easy obtainable information from medical history and physical examination. Measurement of pulse rate, body mass index, blood lipids, fibrinogen level and ECG characteristics do not contribute to the risk stratification of stroke and have no value in the screening for stroke in the general male population.

Full Text

The Full Text of this article is available as a PDF (145.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. M., Wilson P. W., Odell P. M., Kannel W. B. An updated coronary risk profile. A statement for health professionals. Circulation. 1991 Jan;83(1):356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
  2. Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991 Jun 22;337(8756):1521–1526. doi: 10.1016/0140-6736(91)93206-o. [DOI] [PubMed] [Google Scholar]
  3. Bots M. L., Hoes A. W., Koudstaal P. J., Hofman A., Grobbee D. E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997 Sep 2;96(5):1432–1437. doi: 10.1161/01.cir.96.5.1432. [DOI] [PubMed] [Google Scholar]
  4. Boysen G., Nyboe J., Appleyard M., Sørensen P. S., Boas J., Somnier F., Jensen G., Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988 Nov;19(11):1345–1353. doi: 10.1161/01.str.19.11.1345. [DOI] [PubMed] [Google Scholar]
  5. Di Minno G., Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis. 1990 Jan-Feb;10(1):1–7. doi: 10.1161/01.atv.10.1.1. [DOI] [PubMed] [Google Scholar]
  6. Dippel D. W., Koudstaal P. J. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group. Stroke. 1997 Apr;28(4):774–776. doi: 10.1161/01.str.28.4.774. [DOI] [PubMed] [Google Scholar]
  7. Donnan G. A., McNeil J. J., Adena M. A., Doyle A. E., O'Malley H. M., Neill G. C. Smoking as a risk factor for cerebral ischaemia. Lancet. 1989 Sep 16;2(8664):643–647. doi: 10.1016/s0140-6736(89)90894-5. [DOI] [PubMed] [Google Scholar]
  8. Elisaf M. The treatment of coronary heart disease: an update. Part 1: An overview of the risk factors for cardiovascular disease. Curr Med Res Opin. 2001;17(1):18–26. [PubMed] [Google Scholar]
  9. Ellekjaer E. F., Wyller T. B., Sverre J. M., Holmen J. Lifestyle factors and risk of cerebral infarction. Stroke. 1992 Jun;23(6):829–834. doi: 10.1161/01.str.23.6.829. [DOI] [PubMed] [Google Scholar]
  10. Greenland S., Finkle W. D. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995 Dec 15;142(12):1255–1264. doi: 10.1093/oxfordjournals.aje.a117592. [DOI] [PubMed] [Google Scholar]
  11. Grobbee D. E., Koudstaal P. J., Bots M. L., Amaducci L. A., Elwood P. C., Ferro J., Freire de Concalves A., Krüger O., Inzitari D., Nikitin Y. Incidence and risk factors of ischaemic and haemorrhagic stroke in Europe. EUROSTROKE: A collaborative study among research centres in Europe: rationale and design. Neuroepidemiology. 1996;15(6):291–300. doi: 10.1159/000109919. [DOI] [PubMed] [Google Scholar]
  12. Hanley J. A., McNeil B. J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983 Sep;148(3):839–843. doi: 10.1148/radiology.148.3.6878708. [DOI] [PubMed] [Google Scholar]
  13. Hanley J. A., McNeil B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 Apr;143(1):29–36. doi: 10.1148/radiology.143.1.7063747. [DOI] [PubMed] [Google Scholar]
  14. Haq I. U., Jackson P. R., Yeo W. W., Ramsay L. E. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet. 1995 Dec 2;346(8988):1467–1471. doi: 10.1016/s0140-6736(95)92477-9. [DOI] [PubMed] [Google Scholar]
  15. Haq I. U., Ramsay L. E., Yeo W. W., Jackson P. R., Wallis E. J. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999 Jan;81(1):40–46. doi: 10.1136/hrt.81.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harrell F. E., Jr, Lee K. L., Mark D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996 Feb 28;15(4):361–387. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  17. Harrell F. E., Jr, Lee K. L., Pollock B. G. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988 Oct 5;80(15):1198–1202. doi: 10.1093/jnci/80.15.1198. [DOI] [PubMed] [Google Scholar]
  18. Hoes A. W., Grobbee D. E., Lubsen J. Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens. 1995 Jul;13(7):805–811. [PubMed] [Google Scholar]
  19. Hoes A. W., Grobbee D. E., Valkenburg H. A., Lubsen J., Hofman A. Cardiovascular risk and all-cause mortality; a 12 year follow-up study in The Netherlands. Eur J Epidemiol. 1993 May;9(3):285–292. doi: 10.1007/BF00146265. [DOI] [PubMed] [Google Scholar]
  20. Hofman A., Grobbee D. E., de Jong P. T., van den Ouweland F. A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991 Jul;7(4):403–422. doi: 10.1007/BF00145007. [DOI] [PubMed] [Google Scholar]
  21. Leng G. C., Papacosta O., Whincup P., Wannamethee G., Walker M., Ebrahim S., Nicolaides A. N., Dhanjil S., Griffin M., Belcaro G. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis. 2000 Sep;152(1):167–174. doi: 10.1016/s0021-9150(99)00447-5. [DOI] [PubMed] [Google Scholar]
  22. Miettinen O. S. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974 May;99(5):325–332. doi: 10.1093/oxfordjournals.aje.a121617. [DOI] [PubMed] [Google Scholar]
  23. Poses R. M., Cebul R. D., Collins M., Fager S. S. The importance of disease prevalence in transporting clinical prediction rules. The case of streptococcal pharyngitis. Ann Intern Med. 1986 Oct;105(4):586–591. doi: 10.7326/0003-4819-105-4-586. [DOI] [PubMed] [Google Scholar]
  24. Pyörälä K., De Backer G., Graham I., Poole-Wilson P., Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994 Oct;15(10):1300–1331. doi: 10.1093/oxfordjournals.eurheartj.a060388. [DOI] [PubMed] [Google Scholar]
  25. Qizilbash N., Jones L., Warlow C., Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ. 1991 Sep 14;303(6803):605–609. doi: 10.1136/bmj.303.6803.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ridker P. M., Stampfer M. J., Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 May 16;285(19):2481–2485. doi: 10.1001/jama.285.19.2481. [DOI] [PubMed] [Google Scholar]
  27. Roest M., Banga J. D., Tempelman M. J., de Groot P. G., Grobbee D. E., Sixma J. J., van der Schouw Y. T. Factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women. Am J Epidemiol. 1999 Apr 1;149(7):665–670. doi: 10.1093/oxfordjournals.aje.a009867. [DOI] [PubMed] [Google Scholar]
  28. Salonen J. T., Salonen R., Seppänen K., Rauramaa R., Tuomilehto J. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation. 1991 Jul;84(1):129–139. doi: 10.1161/01.cir.84.1.129. [DOI] [PubMed] [Google Scholar]
  29. Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J., Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993 Apr 10;306(6883):983–987. doi: 10.1136/bmj.306.6883.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Truelsen T., Lindenstrøm E., Boysen G. Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study. Stroke. 1994 Apr;25(4):802–807. doi: 10.1161/01.str.25.4.802. [DOI] [PubMed] [Google Scholar]
  32. Tuomilehto J., Sarti C., Narva E. V., Salmi K., Sivenius J., Kaarsalo E., Salomaa V., Torppa J. The FINMONICA Stroke Register. Community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. Am J Epidemiol. 1992 Jun 1;135(11):1259–1270. doi: 10.1093/oxfordjournals.aje.a116232. [DOI] [PubMed] [Google Scholar]
  33. Welin L., Svärdsudd K., Wilhelmsen L., Larsson B., Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987 Aug 27;317(9):521–526. doi: 10.1056/NEJM198708273170901. [DOI] [PubMed] [Google Scholar]
  34. Wigton R. S., Connor J. L., Centor R. M. Transportability of a decision rule for the diagnosis of streptococcal pharyngitis. Arch Intern Med. 1986 Jan;146(1):81–83. [PubMed] [Google Scholar]
  35. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]
  36. Willems J. L., Abreu-Lima C., Arnaud P., van Bemmel J. H., Brohet C., Degani R., Denis B., Gehring J., Graham I., van Herpen G. The diagnostic performance of computer programs for the interpretation of electrocardiograms. N Engl J Med. 1991 Dec 19;325(25):1767–1773. doi: 10.1056/NEJM199112193252503. [DOI] [PubMed] [Google Scholar]
  37. Wolf P. A., D'Agostino R. B., Belanger A. J., Kannel W. B. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991 Mar;22(3):312–318. doi: 10.1161/01.str.22.3.312. [DOI] [PubMed] [Google Scholar]
  38. de Bruyne M. C., Mosterd A., Hoes A. W., Kors J. A., Kruijssen D. A., van Bemmel J. H., Hofman A., Grobbee D. E. Prevalence, determinants, and misclassification of myocardial infarction in the elderly. Epidemiology. 1997 Sep;8(5):495–500. doi: 10.1097/00001648-199709000-00004. [DOI] [PubMed] [Google Scholar]
  39. de Bruyne M. C., Mosterd A., Hoes A. W., Kors J. A., Kruijssen D. A., van Bemmel J. H., Hofman A., Grobbee D. E. Prevalence, determinants, and misclassification of myocardial infarction in the elderly. Epidemiology. 1997 Sep;8(5):495–500. doi: 10.1097/00001648-199709000-00004. [DOI] [PubMed] [Google Scholar]
  40. van Bemmel J. H., Kors J. A., van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods Inf Med. 1990 Sep;29(4):346–353. [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES